학술논문

Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results
Document Type
Article
Source
In ESMO Open August 2023 8(4)
Subject
Thoracic Cancers
Language
ISSN
2059-7029